Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11526 posts found.

Victoza

Novo Nordisk’s Victoza launched in China

October 10, 2011 Sales and Marketing Byetta, China, Victoza, diabetes

Novo Nordisk’s Victoza is now available in China, one of the fastest growing diabetes markets in the world. Victoza (liraglutide …
News

US approval for Merck’s Januvia-Zocor combination

October 10, 2011 Sales and Marketing Januvia, Juvisync, Zocor

US regulators have given the green light to the latest in Merck & Co’s stable of brands aimed at type …
News

Janssen launches Incivo in the UK

October 10, 2011 Sales and Marketing Incivek, Incivo

Janssen’s new hepatitis C treatment Incivo has been launched in the UK, one of two new drugs set to advance …
News
merck_co_richard_clark

Merck & Co chairman Richard Clark retires

October 10, 2011 Research and Development, Sales and Marketing appointment, sales and marketing

Richard Clark will step down as chairman of Merck & Co on 1 December after leading the company for six …
Appointment

Delivering an effective forecasting process

October 7, 2011 Sales and Marketing

It’s surprising how many companies struggle to deliver an effective forcasting process despite the millions spent on supply chains.    Accurate …
Feature
Thought Leadership
Novartis

Novartis cuts Lucentis price amid growing pressure

October 7, 2011 Sales and Marketing Lucentis, wet AMD

Novartis has been forced to cut the Swiss price of its eye drug Lucentis by 30% after sharp negotiations with …
News

Actavis plans ‘major’ sales expansion in Latin America

October 6, 2011 Sales and Marketing Actavis, emerging markets, generics

Swiss company Actavis has launched a new business unit to target the fast-growing Latin American generics market. Mirroring the branded …
News
European Parliament

EMA tightens conflict of interest rules

October 6, 2011 Research and Development, Sales and Marketing EMA

The European Medicines Agency is tightening up its conflict of interest rules with a new ‘experts database’. This will allow …
News

Merck appoints new chief strategy officer

October 6, 2011 Manufacturing and Production, Research and Development, Sales and Marketing appointment, manufacturing and production, research and development, sales and marketing

Cuong Viet Do has joined Merck & Co as chief strategy officer, replacing Mervyn Turner who retired from the US …
Appointment
NICE headquarters

NICE to review wider use of off-label prescribing

October 5, 2011 Sales and Marketing off label, off label prescribing

The government has asked NICE to review its plans to give doctors greater freedom for ‘off-label’ prescribing. It wants NICE, …
News
Takeda

Takeda completes Nycomed acquisition, installs new chief executive

October 3, 2011 Sales and Marketing Nycomed, Takeda

Takeda Pharmaceutical Company has completed its acquisition of Nycomed and named Frank Morich as chief executive of the Zurich-based firm. …
News

Trial disappointment for AZ lung cancer drug

October 3, 2011 Research and Development, Sales and Marketing AstraZeneca, selumetinib

AstraZeneca’s lung cancer drug selumetinib has failed to hit its primary endpoint in a Phase II trial. The trial compared …
News

Jean-Pierre Garnier elected chairman of Actelion

October 3, 2011 Sales and Marketing appointment, sales and marketing

Jean-Pierre Garnier has been elected chairman of Swiss biopharmaceutical company Actelion. He has sat on the company’s board since May …
Appointment
GSK

NICE says no to lupus treatment

September 30, 2011 Sales and Marketing Benylsta, GSK, Lupus, NICE

NICE has rejected GSK’s new lupus treatment Benlysta in draft guidance.Co-developed with biotech company HGS, the drug has been hailed …
News

NICE refuses to back Sanofi’s Jevtana

September 30, 2011 Sales and Marketing Jevtana, NICE

NICE has not recommended Sanofi’s prostate cancer drug Jevtana due to its high cost and concerns over its safety data. …
News
The Gateway to Local Adoption Series

Latest content

China approves fruquintinib combination for kidney cancer

May 29, 2026

BIOTRONIK, Charité and GHCF launch digital cardiology partnership

May 28, 2026

Endometriosis study begins recruitment in UK hospitals

May 28, 2026

MHRA authorises donidalorsen for hereditary angioedema prevention

May 27, 2026

Partnership aims to expand early access to medicines

May 26, 2026